The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review

The endogenous cannabinoid (eCB) system plays an important role in the pathophysiology of both psychotic disorders and substance use disorders (SUDs). The non-psychoactive cannabinoid compound, cannabidiol (CBD) is a highly promising tool in the treatment of both disorders. Here we review human clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Batalla, Albert, Janssen, Hella, Gangadin, Shiral S., Bossong, Matthijs G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678854/
https://www.ncbi.nlm.nih.gov/pubmed/31330972
http://dx.doi.org/10.3390/jcm8071058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678854/
https://www.ncbi.nlm.nih.gov/pubmed/31330972
http://dx.doi.org/10.3390/jcm8071058

Ejemplares similares